These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease. Di Bello V, Bellina CR, Gori E, Molea N, Talarico L, Boni G, Magagnini E, Matteucci F, Giorgi D, Lazzeri E, Bertini A, Romano MF, Bianchi R, Giusti C. J Nucl Cardiol; 1996 Dec; 3(3):212-20. PubMed ID: 8805741 [Abstract] [Full Text] [Related]
14. Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: limitations and concordance. Smart SC, Bhatia A, Hellman R, Stoiber T, Krasnow A, Collier BD, Sagar KB. J Am Coll Cardiol; 2000 Oct; 36(4):1265-73. PubMed ID: 11028482 [Abstract] [Full Text] [Related]
15. Comparison of thallium-201 exercise SPECT and dobutamine stress echocardiography for diagnosis of coronary artery disease in patients with left bundle branch block. Tandoğan I, Yetkin E, Yanik A, Ulusoy FV, Temizhan A, Cehreli S, Sasmaz A. Int J Cardiovasc Imaging; 2001 Oct; 17(5):339-45. PubMed ID: 12025947 [Abstract] [Full Text] [Related]
18. Significance of resting wall motion abnormalities in 2-dimensional echocardiography in patients without previous myocardial infarction referred for pharmacologic stress testing. Elhendy A, van Domburg RT, Bax JJ, Roelandt JR. J Am Soc Echocardiogr; 2000 Jan; 13(1):1-8. PubMed ID: 10625825 [Abstract] [Full Text] [Related]